Futures Strengthen on Tariff Developments
Stock futures rose slightly Wednesday as investors monitor the latest tariff updates from President Donald Trump.Futures for the Dow Jones Industrials hiked 70 points, or 0.2%, to 44,582.Futures for the S&P 500 index collected 8.75 points, or 0.2%, to 6,280.75.Futures for the NASDAQ gave up 30.25 points, or 0.1%, to 22,927.On Tuesday, Trump said in a Truth Social post that there would be no change or extensions on the raft of duties he announced on those nations, which include Japan and South Korea. The new tariff rates range from 25% to 40% and are set to begin on Aug. 1.Trump on Tuesday also announced a 50% levy on copper imports and hinted that further sector-specific tariffs will soon be announced. He threatened Tuesday afternoon to impose up to 200% tariffs on pharmaceuticals imported into the U.S., but said that he will “give people about a year, year and a half” until the duties go into effect.In addition to watching further tariff policy developments on Wednesday, traders will be monitoring the release of the Federal Open Market Committee’s minutes from its last meeting.In Japan, the Nikkei 225 index gained 0.3% Wednesday, while in Hong Kong, the Hang Seng dwindled 1.1%Oil prices edged up 0.25 cents to $68.58 U.S. a barrel. Gold prices dulled $14.50 to $3,302.40 U.S. an ounce.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


